Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-25-000100

Chief Legal Officer sold 3,841 shares at $12.01 ($46,134)

  • Chief Legal Officer acquired 10,532 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · Chief Legal Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-07-30 Exercise or conversion : show line 1 in the form +1,924 39,242 D
2025-07-30 Exercise or conversion : show line 2 in the form +2,000 41,242 D
2025-07-30 Exercise or conversion : show line 3 in the form +3,750 44,992 D
2025-07-30 Exercise or conversion : show line 4 in the form +2,858 47,850 D
2025-07-30 Sale : show line 5 in the form −3,841 $12.01 $46,134 44,009 D
Open-market sales · 3,841 sh · avg $12.01 · $46,134

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2025-07-30 Exercise or conversion : show line 6 in the form Restricted Stock Units −1,924 3,849 D
2025-07-30 Exercise or conversion : show line 7 in the form Restricted Stock Units −2,000 6,000 D
2025-07-30 Exercise or conversion : show line 8 in the form Restricted Stock Units −3,750 26,250 D
2025-07-30 Exercise or conversion : show line 9 in the form Restricted Stock Units −2,858 31,442 D
Loading xslF345X05/wk-form4_1753915738.xml…